Effervescent And Chewing Tablet Market Report 2026

Effervescent And Chewing Tablet Market Overview

• Effervescent And Chewing Tablet market size has reached to $4.88 billion in 2025 • Expected to grow to $8.74 billion in 2030 at a compound annual growth rate (CAGR) of 12.4% • Growth Driver: Digestive Issues Propel Growth Of The Effervescent And Chewing Tablet Market • Market Trend: Innovative Immune Support Formula Combines Enhanced Nutrients With Convenient, Flavorful Delivery • North America was the largest region in 2025.

What Is Covered Under Effervescent And Chewing Tablet Market?

Effervescent and chewing tablets are oral dosage forms designed for rapid disintegration and absorption. Effervescent tablets dissolve in water to release carbon dioxide, creating a fizzy solution that facilitates quicker absorption. Chewing tablets, on the other hand, are designed to be chewed before swallowing, allowing for direct contact with the saliva and a faster onset of action. The main types of effervescent and chewing tablets are effervescent tablet and chewing tablets. An effervescent tablet is a tablet that dissolves in water, releasing carbon dioxide to form a fizzy solution, commonly used for fast-acting medication, nutritional supplementation, and electrolyte replacement. These products are distributed through various channels, including pharmacies and drug stores, supermarkets and hypermarkets, online retailers, and healthcare practitioners. They are used for diverse applications such as healthcare, nutritional supplementation, weight management, and cosmetics, and users of these tablets include adults, children, seniors, and athletes.

What Is The Effervescent And Chewing Tablet Market Growth Forecast?

The effervescent and chewing tablet market size is expected to see rapid growth in the next few years. It will grow to $8.74 billion in 2030 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to growing health-conscious population, rising demand for sports and fitness supplements, innovation in flavor and formulation technologies, expansion of online healthcare retail, increasing focus on preventive nutrition. Major trends in the forecast period include growing preference for fast-absorbing oral dosage forms, rising demand for nutritional and vitamin supplements, increasing adoption of sugar-free chewing tablets, expansion of consumer-friendly drug delivery formats, higher use in preventive healthcare and wellness.

What Is The Driver Of The Effervescent And Chewing Tablet Market?

The rising prevalence of digestive disorders is expected to propel the growth of the effervescent and chewing tablet market going forward. Digestive disorders refer to conditions affecting the gastrointestinal tract, including indigestion, bloating, heartburn, and chronic inflammatory diseases. The prevalence of digestive disorders is increasing due to unhealthy diets, high stress levels, sedentary lifestyles, and the growing consumption of processed foods. The effervescent and chewing tablet market supports digestive health by providing fast-acting, convenient relief for mild gastrointestinal discomfort. For instance, in September 2023, according to the IBD Clinical and Research Centre, a Canada-based non-profit organization, Canada recorded a prevalence of 825 cases per 100,000 people in 2023, representing more than 320,000 individuals living with inflammatory bowel disease (IBD), with projections indicating the population will rise to 470,000 Canadians by 2035. Therefore, the rising prevalence of digestive disorders is driving the growth of the effervescent and chewing tablet industry.

Key Players In The Global Effervescent And Chewing Tablet Market

Major companies operating in the effervescent and chewing tablet market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Sanofi SA, Abbott Laboratories, Teva Pharmaceutical Industries, Amway Corp., Sun Pharmaceutical Industries Ltd., Herbalife International Inc., Dr Reddy's Laboratories Ltd., Leo Nutriscience, Bliss GVS Pharma Limited, Tower Laboratories Ltd., Vitabiotics Ltd., Losan Pharma GmbH, Nutra Healthcare Private Limited, Vovantis Laboratories Pvt. Ltd., BHI Biohealth International GmbH, Nutrilo GmbH, PharmaEstica Manufacturing OÜ, The Himalayan Organics, The Vitamin Company

Global Effervescent And Chewing Tablet Market Trends and Insights

Major companies in the effervescent and chewing tablet market are focusing on developing innovative solutions, such as enhanced nutrient formulations and convenient delivery formats, to boost consumer compliance and product efficacy. Enhanced nutrient formulations are products designed with higher or optimized levels of vitamins, minerals, or other active ingredients for better health benefits, while convenient delivery formats refer to easy-to-use forms like chewable tablets or effervescent tablets that improve user experience and compliance. For instance, in September 2023, Reckitt Benckiser Group plc, a UK-based multinational consumer goods company, launched Airborne’s most comprehensive immune support formula, perfectly timed for the back-to-school season. The reformulated effervescent and chewable supplements now feature seven essential immune-supporting nutrients, Vitamin C, Vitamin D, Zinc, Vitamin A, Vitamin E, Manganese, and Selenium with increased Zinc levels and the addition of Vitamin D. Designed to deliver more complete daily immune support, the formula provides 20% or more of the daily value for each nutrient. Available in Zesty Orange, Very Berry, and Citrus flavors, the product can be found at major retailers including Walmart, Walgreens, Target, and CVS.

What Are Latest Mergers And Acquisitions In The Effervescent And Chewing Tablet Market?

In November 2025, Nextpharma Holdings Ltd., a Norway-based pharmaceutical contract development and manufacturing company, acquired Takeda’s state-of-the-art chewable tablet manufacturing site in Asker for an undisclosed amount. With this acquisition, NextPharma aims to enhance its manufacturing capabilities and strengthen its position in the European oral dosage market. Takeda Pharmaceutical Company Limited is a Japan-based multinational pharmaceutical company that specializes in developing and producing a wide range of pharmaceutical products, including advanced chewable and oral tablet formulations.

What Defines the Effervescent And Chewing Tablet Market?

The effervescent and chewing tablet market consists of sales of vitamin and mineral supplements, pain relief tablets, and gastrointestinal relief products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Effervescent And Chewing Tablet Market Report 2026?

The effervescent and chewing tablet market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the effervescent and chewing tablet industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.